Investigational drug helps opioid-induced constipation

10/25/2012 | MedPage Today

The investigational opioid antagonist drug TD-1211 eased opioid-induced constipation for chronic pain patients compared with a placebo, researchers told a gastroenterology conference. The effect lasted for at least three weeks and the drug did not interfere with the pain medication.

View Full Article in:

MedPage Today

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Associate Director, Promotion Integrity
Bristol-Myers Squibb
Plainsboro, NJ
Vice President, Medicare Advantage
BCBS-Louisiana
Baton Rouge, LA
Director, Global Integrity and Compliance, Pharmaceuticals
Alcon
Fort Worth, TX